Table 2 Risk of malignant tumours in men up to age 99 after a histopathological verified diagnosis of gynecomastia 1970–79. Follow up time includes 1970–1999 (8375.2 years). The cohort consists of 446 men.
From: Male gynecomastia and risk for malignant tumours – a cohort study
Diagnosis | OBS | EXP | SIR | 95% Confidence | interval | |
|---|---|---|---|---|---|---|
140–209 | All malignant tumours | 68 | 66.07 | 1.03 | 0.80 | 1.30 |
140 | Lip | 1 | 0.70 | 1.43 | 0.04 | 7.97 |
141_3_4 | Oral cavity | 0 | 0.51 | 0.00 | 0.00 | 7.18 |
142 | Parotid glands | 0 | 0.19 | 0.00 | 0.00 | 19.71 |
145–148 | Pharynx, hypopharynx | 0 | 0.42 | 0.00 | 0.00 | 8.69 |
150 | Esophagus | 3 | 0.78 | 3.82 | 0.79 | 11.17 |
151 | Stomach | 3 | 4.09 | 0.73 | 0.15 | 2.15 |
153 | Colon | 7 | 5.43 | 1.29 | 0.52 | 2.66 |
154 | Rectum | 0 | 3.57 | 0.00 | 0.00 | 1.03 |
1550 | Liver and intrahepatic ducts | 1 | 0.94 | 1.06 | 0.03 | 5.90 |
1551–1559 | Gallblader & bile ducts | 1 | 0.67 | 1.50 | 0.04 | 8.34 |
157 | Pancreas | 1 | 1.95 | 0.51 | 0.01 | 2.86 |
160 | Nasal cavities & sinus | 0 | 0.13 | 0.00 | 0.00 | 27.71 |
161 | Larynx | 0 | 0.65 | 0.00 | 0.00 | 5.67 |
1620–1621 | Trachea & lung | 6 | 6.31 | 0.95 | 0.35 | 2.07 |
1622 | Mesothelioma | 0 | 0.31 | 0.00 | 0.00 | 12.04 |
170 | Male breast cancer | 0 | 0.09 | 0.00 | 0.00 | 42.96 |
177 | Prostate | 16 | 16.21 | 0.99 | 0.56 | 1.60 |
178 | Testicle | 3 | 0.52 | 5.82 | 1.20 | 17.00 |
180 | Kidney | 1 | 2.18 | 0.46 | 0.01 | 2.55 |
181 | Urinary bl,.urinary tc. | 1 | 4.85 | 0.21 | 0.01 | 1.15 |
190 | Melanoma | 0 | 1.73 | 0.00 | 0.00 | 2.1 |
191 | Skin excl melanoma | 13 | 4.06 | 3.21 | 1.71 | 5.48 |
193 | Brain & nervous system | 1 | 1.71 | 0.59 | 0.01 | 3.26 |
194 | Thyroid | 0 | 0.30 | 0.00 | 0.00 | 12.43 |
196–197 | Bone & soft tissue | 0 | 0.49 | 0.00 | 0.00 | 7.59 |
200+202 | Non-Hodgkin's lymphoma | 1 | 1.96 | 0.51 | 0.01 | 2.84 |
201 | Hodgkin's disease | 0 | 0.28 | 0.00 | 0.00 | 12.97 |
203 | Multiple myeloma | 0 | 0.90 | 0.00 | 0.00 | 4.11 |
Acute leukemia | 1 | 0.54 | 1.86 | 0.05 | 10.38 | |
204.1 | Chr. lymph. leukemia | 0 | 0.74 | 0.00 | 0.00 | 4.98 |
205.1 | Chr myeloid leukemia | 0 | 0.18 | 0.00 | 0.00 | 20.83 |
208 | Polycythemia vera | 0 | 0.17 | 0.00 | 0.00 | 21.67 |